ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
Promotion
Recombinantタンパク質s ClearClear history
Recombinantタンパク質s CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP IL-2 Hot |Omicron specific antibody Hot |Claudin 18.2 |Cadherin-17
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > uPAR

uPAR

概要

Name:Urokinase plasminogen activator surface receptor
Target Synonym:Monocyte activation antigen Mo3,U-PAR,uPAR,CD87,Urokinase-Type Plasminogen Activator (UPA) Receptor,URKR,U-Plasminogen Activator Receptor Form 2,CD87 Antigen,Plasminogen Activator, Urokinase Receptor,MO3
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:4
Lastest Research Phase:Phase 2 Clinical

製品リスト製品比較と製品注文

製品> フィルター結果
製品仕様別：
製品カテゴリー別：
種類別：
タグ別：
コンジュゲート：
製造番号 種類 製品説明 構造 純度 特徴
CHEK-ATP151 Human HEK293/Human uPAR Stable Cell Line
SCCHO-ATP152 Human CHO/Human uPAR Stable Cell Line Development Service
MBS-K076 Human Human uPAR-coupled Magnetic Beads
UPR-HA2H9 Human APC-Labeled Human uPAR / PLAUR Protein, His Tag (Site-specific conjugation)
UPR-HA2H9-structure
UPR-M52H3 Mouse Mouse uPAR / PLAUR Protein, His Tag (SPR verified)
UPR-M52H3-structure
UPR-M52H3-sds
UPR-H52H4 Human Human uPAR / PLAUR (112-303) Protein, His Tag
UPR-H52H4-structure
UPR-H52H4-sds
UPR-H52H6 Human Human uPAR / PLAUR (209-303) Protein, His Tag
UPR-H52H6-structure
UPR-H52H6-sds
UPR-HP2H7 Human PE-Labeled Human uPAR / PLAUR Protein, His Tag (Site-specific conjugation)
UPR-HP2H7-structure
UPR-H5254 Human Human uPAR / PLAUR Protein, Fc Tag (MALS verified)
UPR-H5254-structure
UPR-H5254-sds
UPR-HF2H3 Human FITC-Labeled Human uPAR / PLAUR Protein, His Tag
UPR-HF2H3-structure
UPR-HF2H3-sds
UPR-H82E7 Human Biotinylated Human uPAR / PLAUR Protein, His,Avitag™ (MALS verified)
UPR-H82E7-structure
UPR-H82E7-sds
UPR-H5226 Human Human uPAR / PLAUR Protein, His Tag (MALS verified)
UPR-H5226-structure
UPR-H5226-sds
ACRO Quality

生物活性データの一部

CHEK-ATP151-Cell-based assay
uPAR FACS

Expression analysis of human uPAR on HEK293/Human uPAR Stable Cell Line by FACS.
Cell surface staining was performed on HEK293/Human uPAR Stable Cell Line or negative control cell using PE-labeled anti-human uPAR antibody.

Protocol
SCCHO-ATP152-Cell-based assay
uPAR FACS

Expression analysis of human uPAR on CHO/Human uPAR Stable Cell Line by FACS.
Cell surface staining was performed on CHO/Human uPAR Stable Cell Line or negative control cell using PE-labeled anti-human uPAR antibody.

Protocol
UPR-M52H3-SPR
Human_FcRn_Heterodimer_Protein_SPR

Mouse uPAR, His Tag (Cat. No. UPR-M52H3) immobilized on CM5 Chip can bind Human PLAU, His Tag (Cat. No. PLU-H5229) with an affinity constant of 14.1 nM as determined in a SPR assay (Biacore 8K) (QC tested).

Protocol
UPR-HF2H3-ELISA
FITC-Labeled Human uPAR, His TagFITC-Labeled Human uPAR, His Tag (Cat. No. UPR-HF2H3) ELISA bioactivity

Immobilized Anti-uPAR Antibody, Mouse IgG1 at 1 μg/mL (100 μL/well) can bind FITC-Labeled Human uPAR, His Tag (Cat. No. UPR-HF2H3) with a linear range of 39-156 ng/mL (QC tested).

Protocol

Synonym Name

uPAR,PLAUR,CD87,MO3

Background

Urokinase plasminogen activator surface receptor (U-PAR) is also known as PLAUR, Monocyte activation antigen Mo3, CD antigen CD87. PLAUR contains three UPAR/Ly6 domains. U-PAR is expressed in neurons of the rolandic area of the brain (at protein level) and is also expressed in the brain. PLAUR / CD87 interacts with MRC2, SRPX2 and SORL1. PLAUR / UPAR acts as a receptor for urokinase plasminogen activator and plays a role in localizing and promoting plasmin formation. U-PAR mediates the proteolysis-independent signal transduction activation effects of U-PA.

Clinical and Translational Updates

臨床試験情報

Name Research Code Research Phase Company Indications Clinical Trials
WAL-0921 WAL0921; WAL-0921 Phase 1 Clinical Walden Biosciences Inc Renal Insufficiency, Chronic Details
FG001 FG-001; FG001 Phase 2 Clinical FluoGuide AS Head and Neck Neoplasms; Brain Neoplasms; Glioma; Lung Neoplasms; Meningioma Details
KMHH-03 KMHH-03; KMHH03 Phase 1 Clinical Beijing Kangming Haihui Biological Technology Co Ltd Breast Neoplasms Details
Gallium-68 NOTA AE105 (Curasight) CS-001; 68Ga-NOTA-AE105 Phase 2 Clinical Rigshospitalet, Curasight Aps Bone metastases; Head and Neck Neoplasms; Neoplasms; Glioblastoma; Urinary Bladder Neoplasms; Neuroendocrine Tumors; Mesothelioma; Prostatic Neoplasms; Breast Neoplasms; Oropharyngeal Neoplasms; Genital Neoplasms, Female; Mouth Neoplasms; Carcinoma, Non-Small-Cell Lung Details

This web search service is supported by Google Inc.

totopphone
Call us
お問い合わせ
グローバル：+1 800-810-0816(Toll Free)
日本：+(0)81-50-547-99099
Email
メールアドレス
order.jp@acrobiosystems.com
Fax
ファックス
+1 888-377-6111
Address
株式会社アクロバイオシステムズ
〒157-0066
東京都世田谷区成城1丁目26番9-101号

アクロバイオシステムズの公式アカウント

linkedin twitter facebook youtube

お問い合わせ（半角英文字で入力してください）

Copyright © 2017 ACROBiosystems. All Rights Reserved
Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap